135 related articles for article (PubMed ID: 28445304)
101. Genetic Polymorphisms of
Oliveira-Toré CF; Moraes AG; Martinez GF; Neves JSF; Macedo LC; Rocha-Loures MA; Quirino MG; Alves HV; Sell AM; Visentainer JEL
J Immunol Res; 2019; 2019():1492092. PubMed ID: 31781672
[TBL] [Abstract][Full Text] [Related]
102. Increased expression of TLR9 associated with pro-inflammatory S100A8 and IL-8 in diabetic wounds could lead to unresolved inflammation in type 2 diabetes mellitus (T2DM) cases with impaired wound healing.
Singh K; Agrawal NK; Gupta SK; Sinha P; Singh K
J Diabetes Complications; 2016; 30(1):99-108. PubMed ID: 26525587
[TBL] [Abstract][Full Text] [Related]
103. Toll-like receptor 2 and 9 genetic polymorphisms and the susceptibility to B cell Non-Hodgkin Lymphoma in Egypt.
Rahman HA; Khorshied MM; Khorshid OM; Mahgoub SM
Ann Hematol; 2014 Nov; 93(11):1859-65. PubMed ID: 24912772
[TBL] [Abstract][Full Text] [Related]
104. Toll-like receptor expression and signaling in human diabetic wounds.
Dasu MR; Martin SJ
World J Diabetes; 2014 Apr; 5(2):219-23. PubMed ID: 24748934
[TBL] [Abstract][Full Text] [Related]
105. Association of variant rs7903146 (C/T) single nucleotide polymorphism of TCF7L2 gene with impairment in wound healing among north Indian type 2 diabetes population: a case-control study.
Singh K; Agrawal NK; Gupta SK; Singh K
Int J Low Extrem Wounds; 2013 Dec; 12(4):310-5. PubMed ID: 24214952
[TBL] [Abstract][Full Text] [Related]
106. Amelioration in wound healing in diabetic toll-like receptor-4 knockout mice.
Dasu MR; Jialal I
J Diabetes Complications; 2013; 27(5):417-21. PubMed ID: 23773694
[TBL] [Abstract][Full Text] [Related]
107. Toll-like receptor 2 in promoting angiogenesis after acute ischemic injury.
Xu Y; Zhou Y; Lin H; Hu H; Wang Y; Xu G
Int J Mol Med; 2013 Mar; 31(3):555-60. PubMed ID: 23314218
[TBL] [Abstract][Full Text] [Related]
108. Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair.
Kuo IH; Carpenter-Mendini A; Yoshida T; McGirt LY; Ivanov AI; Barnes KC; Gallo RL; Borkowski AW; Yamasaki K; Leung DY; Georas SN; De Benedetto A; Beck LA
J Invest Dermatol; 2013 Apr; 133(4):988-98. PubMed ID: 23223142
[TBL] [Abstract][Full Text] [Related]
109. Association of Toll-like receptor 2 polymorphisms with papillary thyroid cancer and clinicopathologic features in a Korean population.
Kim MK; Park SW; Kim SK; Park HJ; Eun YG; Kwon KH; Kim J
J Korean Med Sci; 2012 Nov; 27(11):1333-8. PubMed ID: 23166414
[TBL] [Abstract][Full Text] [Related]
110. Frequency of TLR 2, 4, and 9 gene polymorphisms in Chinese population and their susceptibility to type 2 diabetes and coronary artery disease.
Liu F; Lu W; Qian Q; Qi W; Hu J; Feng B
J Biomed Biotechnol; 2012; 2012():373945. PubMed ID: 23091345
[TBL] [Abstract][Full Text] [Related]
111. Toll-like receptors and diabetes complications: recent advances.
Rosa Ramirez S; Ravi Krishna Dasu M
Curr Diabetes Rev; 2012 Nov; 8(6):480-8. PubMed ID: 22934553
[TBL] [Abstract][Full Text] [Related]
112. The association between Toll-like receptor 2 single-nucleotide polymorphisms and hepatocellular carcinoma susceptibility.
Junjie X; Songyao J; Minmin S; Yanyan S; Baiyong S; Xiaxing D; Jiabin J; Xi Z; Hao C
BMC Cancer; 2012 Feb; 12():57. PubMed ID: 22309608
[TBL] [Abstract][Full Text] [Related]
113. Toll-like receptor 2 gene polymorphisms associated with aggressive periodontitis in Japanese.
Takahashi M; Chen Z; Watanabe K; Kobayashi H; Nakajima T; Kimura A; Izumi Y
Open Dent J; 2011; 5():190-4. PubMed ID: 22235236
[TBL] [Abstract][Full Text] [Related]
114. Association studies of gene polymorphisms in toll-like receptors 2 and 4 in Croatian patients with acute myocardial infarction.
Džumhur A; Zibar L; Wagner J; Simundić T; Dembić Z; Barbić J
Scand J Immunol; 2012 May; 75(5):517-23. PubMed ID: 22229967
[TBL] [Abstract][Full Text] [Related]
115. The C allele of rs5743836 polymorphism in the human TLR9 promoter links IL-6 and TLR9 up-regulation and confers increased B-cell proliferation.
Carvalho A; Osório NS; Saraiva M; Cunha C; Almeida AJ; Teixeira-Coelho M; Ludovico P; Pedrosa J; Pitzurra L; Aversa F; Romani L; Castro AG; Rodrigues F
PLoS One; 2011; 6(11):e28256. PubMed ID: 22132241
[TBL] [Abstract][Full Text] [Related]
116. Toll-like receptor 4 single-nucleotide polymorphisms Asp299Gly and Thr399Ile in head and neck squamous cell carcinomas.
Bergmann C; Bachmann HS; Bankfalvi A; Lotfi R; Pütter C; Wild CA; Schuler PJ; Greve J; Hoffmann TK; Lang S; Scherag A; Lehnerdt GF
J Transl Med; 2011 Aug; 9():139. PubMed ID: 21854645
[TBL] [Abstract][Full Text] [Related]
117. VEGF gene polymorphism association with diabetic foot ulcer.
Amoli MM; Hasani-Ranjbar S; Roohipour N; Sayahpour FA; Amiri P; Zahedi P; Mehrab-Mohseni M; Heshmat R; Larijani B; Tavakkoly-Bazzaz J
Diabetes Res Clin Pract; 2011 Aug; 93(2):215-219. PubMed ID: 21596454
[TBL] [Abstract][Full Text] [Related]
118. Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9.
Guiducci C; Tripodo C; Gong M; Sangaletti S; Colombo MP; Coffman RL; Barrat FJ
J Exp Med; 2010 Dec; 207(13):2931-42. PubMed ID: 21115693
[TBL] [Abstract][Full Text] [Related]
119. TLR2 expression and signaling-dependent inflammation impair wound healing in diabetic mice.
Dasu MR; Thangappan RK; Bourgette A; DiPietro LA; Isseroff R; Jialal I
Lab Invest; 2010 Nov; 90(11):1628-36. PubMed ID: 20733560
[TBL] [Abstract][Full Text] [Related]
120. CD14-159C/T and TLR9-1237T/C polymorphisms are not associated with gastric cancer risk in Caucasian populations.
Hold GL; Rabkin CS; Gammon MD; Berry SH; Smith MG; Lissowska J; Risch HA; Chow WH; Mowat NA; Vaughan TL; El-Omar EM
Eur J Cancer Prev; 2009 Apr; 18(2):117-9. PubMed ID: 19337058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
